Our study indicates that RASi exposure is not associated with an increase nor decrease in the risk of inhospital all-cause mortality (adjusted OR 0.66, 95% CI 0.31–1.40, p =0.226), even though the odds showed a nonsignificant trend of decrease in the exposed group after adjusting for age and comorbidities (logistic regression coefficient of −0.42) ( Table 2 ).
← all excerpts
The Effect of Chronic and Inhospital Exposure to Renin-Angiotensin System Inhibitors on the Outcome and Inflammatory State of Coronavirus Disease 2019 Adult Inpatients.
1
—
—